ATS 2019 Virtual Final Program

3:25 Legal Advocacy to Improve Lung Health M. Lieberman, JD, Charlottesville, VA 3:35 Lung Doctors, Lawyers, and Labor: Advocating So That Workers Might Breathe R.A. Cohen, MD, Chicago, IL 3:47 Patient Interview B. Brock, Wise, VA 3:55 Patient-Centered Advocacy: The Allergy and Asthma Network T. Winders, MBA, Vienna, VA 4:05 Advocacy Through Community Partnerships: The Not One More Life Story L.M. Graham, MD, Atlanta, GA BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 B92 ATS FAMILY OF JOURNALS IN 2019 Publications Policy Committee 2:15 p.m. - 4:15 p.m. KBHCCD Room C146 (Level 1) Target Audience This session is of benefit to both junior and senior clinicians and researchers, including basic researchers. The session will cover all 3 journals of the ATS and will be of interest to all ATS Assemblies and conference attendees. Objectives At the conclusion of this session, the participant will be able to: o discuss the impact and benefits to the research and clinical community of the ATS having a Family of Journals; • describe common issues in manuscripts submitted to journals, including journal impact factors and metrics, reporting of clinical trials and reporting results of observational studies; • increase the participation of early career researchers in peer review and editorial activities. In this session we will address the role of the ATS Journal family and how this can benefit the scientific and clinical community.We will also address some interesting issues in publication and review key papers published on topics across the Blue, White and Red journals. Chairing: B.D. Levy, MD, ATSF, Boston, MA F.J. Martinez, MD, MS, New York, NY G.C. Donaldson, PhD, BSc(Hons), London, United Kingdom 2:15 Benefits of the ATS Family of Journals J.A. Wedzicha, MD, PhD, ATSF, London, United Kingdom 2:30 Journal Impact Factors and Metrics P.T. Schumacker, PhD, ATSF, Chicago, IL 2:45 COPD Across ATS Journals M.K. Han, MD, MS, Ann Arbor, MI 3:00 Airway Biology in the ATS Journal Family L. Donnelly, BSc(Hons), PhD, London, United Kingdom 3:15 Critical Care Across ATS Journals L.J. Brochard, MD, Toronto, Canada 3:30 How to Successfully Write Manuscripts on Clinical Trials? K.F. Rabe, MD, PhD, Grosshansdorf, Germany 3:45 Causal Inference and Reporting of Results in Observational Studies D.J. Lederer, MD, MS, New York, NY 4:00 Involving Early Career Researchers in Journal Peer Review J. Allinson, MRCP(UK), London, United KingdomBASIC • CLINICAL MINI SYMPOSIUM B93 COPD: MORTALITY AND RISK PREDICTION 2:15 p.m. - 4:15 p.m. KBHCCD Room C155-C156 (Level 1) Chairing: D.M.G. Halpin, PhD, Exeter, United Kingdom Oral Presentations 2:15 Causes and Predictors of Death in Smokers with and Without COPD: An Analysis of the COPDGene Cohort/ W.W. Labaki, T. Gu, S. Murray, J.L. Curtis, X. Soler, S.P. Bhatt, J.M. Bon, T. Beaty, J.E. Hokanson, D. Curran-Everett, R.P. Bowler, B.J. Make, E.A. Regan, E.K. Silverman, J.D. Crapo, M.K. Han, Ann Arbor, MI, p.A3995 2:30 Improved COPD Mortality Prediction Using Machine Learning in the COPDGene and ECLIPSE Studies/ M. Moll, E.A. Regan, G.M. Hunninghake, J. Vestbo, B.J. Make, R. Tal-Singer, M.K. Han, E.K. Silverman, M.H. Cho, B.D. Hobbs, Boston, MA, p.A3996 2:45 In-Hospital Mortality Trends for Alpha-1 Antitrypsin Deficiency in the United States/ A. Attaway, U.S. Hatipoglu, U. Majumdar, X. Wang, X. Han, J.K. Stoller, Cleveland, OH, p.A3997 3:00 Creation and Validation of the Summit Score for Mortality and Morbidity Risk Stratification and Therapeutic Use for Chronic Obstructive Pulmonary Disease/ B.D. Horne, M.J. Hegewald, S. Rea, T.L. Bair, D.P. Blagev, Salt Lake City, UT, p.A3998 3:15 Hypogammaglobulinemia as a Predictor of Hospitalizations in COPD: A Meta-Analysis/ F.S.S. Leitao Filho, A. Mattman, R. Schellenberg, G.J. Criner, P. Woodruff, R.K. Albert, J. Connett, S.C. Lazarus, M.K. Han, F.J. Martinez, A.L. Fuhlbrigge, J.K. Stoller, N.R. MacIntyre, T. Stibolt, R. Casaburi, P. Diaz, R.J. Panos, J.A.D. Cooper, Jr., S.E. Gay, F.C. Sciurba, R.E. Kanner, D.H. Au, R.D. Yusen, W.C. Bailey, K.C. Pike, V.S. Fan, J.M. Leung, S.F. Paul Man, S.D. Aaron, R.M. Reed, D.D. Sin, Vancouver, Canada, p.A3999 3:30 Hemoglobin as a Biomarker for Clinical Outcomes in Chronic Obstructive Pulmonary Disease/ A. Balasubramanian, R. Henderson, N. Putcha, A. Fawzy, S. Raju, N.N. Hansel, N.R. MacIntyre, R.L. Jensen, G.L. Kinney, W.W. Stringer, C.P. Hersh, R.P. Bowler, R. Casaburi, M.K. Han, J. Porszasz, R.G. Barr, B.J. Make, M.C. McCormack, R.A. Wise, Baltimore, MD, p.A4000 ATS 2019 • Dallas, TX 204 MONDAY • MAY 20